Cuprina Holdings (Cayman) LTD CUPR
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-1.42
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $38.8K | $35.5K | — | — |
| Cost of revenue | $39.3K | $37.7K | — | — |
| Gross profit | -$501 | -$2.2K | — | — |
| R&D | $176.4K | $177.4K | $177.4K | — |
| SG&A | $3.6M | $1.0M | — | — |
| Total operating expenses | $3.8M | $1.2M | — | — |
| Operating income | -$3.8M | -$1.2M | — | — |
| Interest expense | $11.4K | $6.1K | — | — |
| Pre-tax income | -$3.6M | -$1.1M | — | — |
| Net income | -$3.6M | -$1.1M | — | — |
| EPS, basic | -1.42 | -6.38 | — | — |
| EPS, diluted | -1.42 | -6.38 | — | — |
| Shares, diluted (wtd. avg.) | $2.6M | $2.2M | $2.2M | $18.0M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | $2.4M | $85.6K | — | — |
| Receivables | $14.2K | $19.4K | — | — |
| Inventory | — | $1.3K | — | — |
| Total current assets | $5.7M | $1.2M | — | — |
| Property, plant and equipment | $60.3K | $42.7K | — | — |
| Total assets | $6.6M | $1.3M | — | — |
| Accounts payable | $915 | — | — | — |
| Short-term debt | $30.1K | $40.6K | — | — |
| Total current liabilities | $2.4M | $4.4M | — | — |
| Long-term debt | $98.1K | $120.4K | — | — |
| Total liabilities | $2.7M | $4.6M | — | — |
| Retained earnings | -$7.2M | -$3.4M | — | — |
| Total equity | $3.9M | -$3.3M | -$3.3M | — |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating cash flow | -$7.1M | -$908.6K | — | — |
| Depreciation and amortisation | $28.4K | $31.0K | — | — |
| Capital expenditure | $45.3K | $16.1K | — | — |
| Investing cash flow | -$45.3K | -$16.1K | — | — |
| Financing cash flow | $9.5M | $985.8K | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-032280.
Others in SIC 3842
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $129.55B | 46.6x | 20.5% |
| EW | Edwards Lifesciences Corp | $51.82B | 49.1x | 11.5% |
| STE | STERIS plc | $21.90B | 28.3x | 8.7% |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | $18.71B | 27.6x | 7.2% |
| ALGN | ALIGN TECHNOLOGY INC | $11.27B | 28.1x | 0.9% |
| MSA | MSA Safety Inc | $7.28B | 26.6x | 3.7% |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $2.21B | — | 27.1% |
| CDRE | Cadre Holdings, Inc. | $1.27B | 29.2x | 7.5% |